(Q41551933)

3 October 2017

1 reference

title

Immunostimulatory cytokines in somatic cells and gene therapy of cancer (English)

1 reference

3 October 2017

0 references

Mackensen A

1

1 reference

3 October 2017

Lindemann A

series ordinal

2

1 reference

3 October 2017

Mertelsmann R

series ordinal

3

1 reference

3 October 2017

publication date

1 June 1997

1 reference

Cytokine and Growth Factor Reviews

3 October 2017

published in

1 reference

3 October 2017

volume

8

1 reference

3 October 2017

issue

2

1 reference

3 October 2017

page(s)

119-128

1 reference

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

MHC antigens and cancer: implications for T-cell surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Prospects for the treatment of B cell tumors using idiotypic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Alterations in T cells of cancer-bearers: whence specificity?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Peri-tumor interleukin-2 causes systemic therapeutic effect via interferon-gamma induction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

A novel approach to the induction of specific cytolytic T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Inhibition of tumor growth by histoincompatible cells expressing interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Interferon-gamma-producing tumor induces host tumor-specific T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Experimental and clinical studies of cytokine gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900052-4

7 January 2021

10.1016/S1359-6101(96)00052-4

Identifiers

DOI

1 reference

3 October 2017

1 reference